Selvaraj Divya , Subramanian Arivoli , Samuel Tennyson
{"title":"Effect of Abelmoschus manihot (L.) Medik chloroform leaf extract on streptozotocin-induced diabetic rats","authors":"Selvaraj Divya , Subramanian Arivoli , Samuel Tennyson","doi":"10.1016/j.prenap.2025.100335","DOIUrl":null,"url":null,"abstract":"<div><div>Ethnomedicine is a potentially fruitful area of study in treating diabetes since plants are reported to possess antidiabetic properties. In this study, <em>Abelmoschus manihot</em> leaf chloroform extract (AMLCE) was assessed for its antidiabetic effect on streptozotocin (STZ)-induced diabetic Wistar albino rats. The experimental design comprised of seven groups with six rats in each group, viz., Group I: Normal control, Group II: STZ (Diabetic control), Group III: STZ + AMLCE [100 mg/Kg BW], Group IV: STZ + AMLCE [200 mg/Kg BW], Group V: STZ + AMLCE [400 mg/Kg BW], Group VI: STZ + Glibenclamide [600 µg/Kg BW], and Group VII: Normal control + AMLCE [400 mg/Kg BW]. Body weight of Group I, II and V were 207.23 ± 8.99, 121.98 ± 7.61 and 162.82 ± 7.18 g, respectively; and their respective plasma glucose levels were 95.31 ± 4.53, 286.93 ± 4.82 and 126.88 ± 7.14 mg/dL. The insulin and total haemoglobin levels of Group I, II and V were 16.62 ± 1.10, 7.20 ± 2.60, 11.90 ± 1.72 µU/mL; and 12.60 ± 1.68, 6.51 ± 0.62, 10.17 ± 0.54 g/dL, respectively. When compared to the STZ-induced diabetic Wistar albino rats, AMLCE significantly increased the body weight and levels of insulin levels and total haemoglobin (<em>P≤</em>0.05) and decreased plasma glucose level (<em>P≤</em>0.05). AMLCE Group V was taken up for further studies since it showed a noteworthy impact in comparison to the other two groups of AMLCE. The histopathological study revealed STZ-induced diabetic Wistar albino rats treated with AMLCE with restoration of β-cells in islet of Langerhans in pancreas, regeneration of hepatocytes in liver, and restoration of glomerulus tubules in kidney. The expression of IR, PI3K, p-Akt, and GLUT-2 protein levels in STZ-induced diabetic Wistar albino rats increased upon treatment with AMLCE. The findings of this investigation suggest that AMLCE exhibited anti-diabetic effect. This study represents the first report on the anti-diabetic effects of AMLCE on STZ-induced diabetic Wistar albino rats.</div></div>","PeriodicalId":101014,"journal":{"name":"Pharmacological Research - Natural Products","volume":"8 ","pages":"Article 100335"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological Research - Natural Products","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950199725001958","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Ethnomedicine is a potentially fruitful area of study in treating diabetes since plants are reported to possess antidiabetic properties. In this study, Abelmoschus manihot leaf chloroform extract (AMLCE) was assessed for its antidiabetic effect on streptozotocin (STZ)-induced diabetic Wistar albino rats. The experimental design comprised of seven groups with six rats in each group, viz., Group I: Normal control, Group II: STZ (Diabetic control), Group III: STZ + AMLCE [100 mg/Kg BW], Group IV: STZ + AMLCE [200 mg/Kg BW], Group V: STZ + AMLCE [400 mg/Kg BW], Group VI: STZ + Glibenclamide [600 µg/Kg BW], and Group VII: Normal control + AMLCE [400 mg/Kg BW]. Body weight of Group I, II and V were 207.23 ± 8.99, 121.98 ± 7.61 and 162.82 ± 7.18 g, respectively; and their respective plasma glucose levels were 95.31 ± 4.53, 286.93 ± 4.82 and 126.88 ± 7.14 mg/dL. The insulin and total haemoglobin levels of Group I, II and V were 16.62 ± 1.10, 7.20 ± 2.60, 11.90 ± 1.72 µU/mL; and 12.60 ± 1.68, 6.51 ± 0.62, 10.17 ± 0.54 g/dL, respectively. When compared to the STZ-induced diabetic Wistar albino rats, AMLCE significantly increased the body weight and levels of insulin levels and total haemoglobin (P≤0.05) and decreased plasma glucose level (P≤0.05). AMLCE Group V was taken up for further studies since it showed a noteworthy impact in comparison to the other two groups of AMLCE. The histopathological study revealed STZ-induced diabetic Wistar albino rats treated with AMLCE with restoration of β-cells in islet of Langerhans in pancreas, regeneration of hepatocytes in liver, and restoration of glomerulus tubules in kidney. The expression of IR, PI3K, p-Akt, and GLUT-2 protein levels in STZ-induced diabetic Wistar albino rats increased upon treatment with AMLCE. The findings of this investigation suggest that AMLCE exhibited anti-diabetic effect. This study represents the first report on the anti-diabetic effects of AMLCE on STZ-induced diabetic Wistar albino rats.